B

BrightSpec, Inc.

20 employees

Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.

Basic info

Industry

biotechnology research

Sectors

Process monitoring
Metabolomics
PAT
medical
Chiral analysis
continuous manufacturing
Chemical Engineering
gas chromatography
Isomers
Bench-top analytical chemistry
Isomer
natural products
spectroscopy
Gas mixture analysis
bio-manufacturing
Test and Measurement
medicinal chemistry
synthetic chemistry
flow chemistry
environmental analysis
chiral
molecular rotational resonance
Protein Degredation
science and environment
cbd
process monitoring
Analytics
chemical analysis
GC-MS
GC-MRR
LC-MS
Deuterated Drugs
Impurity Analysis
structure elucidation
environmental testing
Pharmaceutical impurity analysis

Date founded

2012

Funding rounds raised

Total raised

$18M

from 6 investors over 6 rounds

B

BrightSpec, Inc. raised $18M on December 14, 2022

Investors: Medvest Capital, University of Virginia Patent Foundation, Felton Group LLC and Genoa Ventures

B

BrightSpec, Inc. raised undisclosed on August 1, 2020

Investors: University of Virginia Patent Foundation and CAV Angels

FAQ